{
  "id": 17018061,
  "title": "SK Bioscience joins US-backed project to develop Bundibugyo Ebola vaccine",
  "url": "https://urgent.news/2026/10/29/sk-bioscience-joins-us-backed-project-to-develop-bundibugyo-ebola-17018061",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-29T06:12:03.000Z",
  "source": {
    "name": "The Korea Times",
    "slug": "the-korea-times-koreatimes",
    "url": "https://www.koreatimes.co.kr/business/companies/20261029/sk-bioscience-joins-us-backed-project-to-develop-bundibugyo-ebola-vaccine"
  },
  "original_language": "en",
  "account": "SK Bioscience has announced its participation in a U.S. government-funded initiative aimed at creating and manufacturing a vaccine for the Bundibugyo strain of Ebola, which is currently ravaging the Democratic Republic of the Congo. The project, a collaboration with the International AIDS Vaccine Initiative (IAVI) and Singapore-based Hilleman Laboratories, will be funded up to 130.9 billion won ($99 million) by the Biomedical Advanced Research and Development Authority (BARDA), a division of the U.S. Department of Health and Human Services’ Administration for Strategic Preparedness and Response. The initial allocation of $36 million has already been confirmed. This funding will be utilized for various aspects of the project, including clinical and regulatory work, a Phase 1 trial to assess the vaccine's safety in a small population, and the production and distribution of vaccines for outbreak response. Plans are also in place to develop an enhanced version of the vaccine to combat emerging variant strains. As of Sunday, the Congo outbreak has recorded 10,060 confirmed cases and 4,887 deaths, marking it as the most severe Ebola outbreak to date.",
  "summary": "SK Bioscience will join global partners in a U.S. government-funded project to develop and produce a vaccine against the Bundibugyo virus, a strain of Ebola spreading in the Democratic Republic of the Congo, the Korean vaccine maker said Thursday. The project, carried out with the International AIDS Vaccine Initiative (IAVI), a global nonprofit biomedical research organization, and…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 3,
    "also_reported_by": [
      {
        "outlet": "Ajel English",
        "title": "WHO launches clinical trial for Bundibugyo Ebola vaccines in Congo",
        "url": "https://urgent.news/2026/10/27/who-launches-clinical-trial-for-bundibugyo-ebola-vaccines-in-congo",
        "published": "2026-10-27T12:35:14.000Z"
      },
      {
        "outlet": "Fortune",
        "title": "‘Every life saved is worth celebrating’: Congo suffers over 10,000 cases of the fastest-growing and farthest-reaching Ebola outbreak in history",
        "url": "https://urgent.news/2026/10/28/every-life-saved-is-worth-celebrating-congo-suffers-over-10-000-cases",
        "published": "2026-10-28T15:50:00.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}